Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7716
+0.0136 (1.79%)
Jul 30, 2026, 4:00 PM EDT - Market closed

Rein Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Cash & Equivalents
4.453.224.055.727.4312.8717.6821.9412.0717.3412.0913.197.815.224.867.657.473.637.6310.77
Short-Term Investments
-----------0.58.9416.0520.6424.7530.6342.3344.6348.73
Cash & Short-Term Investments
4.453.224.055.727.4312.8717.6821.9412.0717.3412.0913.6916.7521.2725.532.4138.145.9652.2659.5
Cash Growth (YoY)
-40.16%-75.01%-77.10%-73.92%-38.44%-25.80%46.16%60.27%-27.94%-18.48%-52.58%-57.75%-56.05%-53.73%-51.20%-45.54%-39.88%219.20%269.41%214.75%
Other Current Assets
1.011.111.130.880.90.791.011.220.70.880.70.260.360.611.551.141.892.222.170.65
Total Current Assets
5.454.335.176.68.3313.6618.6823.1612.7618.2712.7913.9517.1121.8727.0533.5539.9948.1854.4260.15
Net Property, Plant & Equipment
---000000.010.070.030.040.050.110.150.20.240.280.320.36
Other Intangible Assets
13.513.542.242.242.242.279.279.279.279.2----------
Goodwill
6.336.336.336.336.336.336.336.336.336.33----------
Other Long-Term Assets
1.01002.350.77000.710.892.19---0.020.020.020.020.020.020.02
Total Assets
26.2924.1653.7157.4857.6362.19104.22109.499.19106.0112.8213.9917.1622.0127.2333.7740.2648.4854.7760.53
Accounts Payable
6.263.984.126.031.150.911.080.782.161.190.480.140.461.720.951.741.021.211.041.02
Accrued Expenses
2.452.21.621.674.834.844.584.162.383.151.141.062.431.633.523.312.993.213.433.16
Short-Term Debt
4.92-------------------
Current Portion of Leases
---------0.05---0.030.070.10.130.090.090.09
Total Current Liabilities
13.646.185.747.695.985.755.664.944.534.391.621.22.883.384.545.154.154.514.564.27
Long-Term Leases
-----------------0.070.10.13
Other Long-Term Liabilities
1.061.061.771.771.772.053.333.443.333.33----------
Total Long-Term Liabilities
1.061.061.771.771.772.053.333.443.333.33-------0.070.10.13
Total Liabilities
14.77.247.529.477.757.88.998.387.867.711.621.22.883.384.545.154.154.584.664.4
Shareholders' Equity
11.5916.9246.1948.0149.8854.3995.23101.0291.3398.311.212.7914.2718.6222.728.6236.1143.950.1156.13
Total Liabilities & Equity
26.2924.1653.7157.4857.6362.19104.22109.499.19106.0112.8213.9917.1622.0127.2333.7740.2648.4854.7760.53
Total Debt
4.92000000000.050000.030.070.10.130.160.190.22
Net Cash (Debt)
-0.483.224.055.727.4312.8717.6821.9412.0717.2912.0913.6916.7521.2325.4432.3137.9745.852.0759.28
Net Cash Growth (YoY)
--75.01%-77.10%-73.92%-38.44%-25.59%46.16%60.27%-27.94%-18.57%-52.45%-57.62%-55.90%-53.63%-51.15%-45.50%-39.52%226.86%475.05%332.75%
Net Cash Per Share
-0.020.130.170.260.350.721.292.342.183.762.663.023.694.685.617.138.3810.3113.6418.66
Tangible Book Value
-19.83-19.83-48.53-48.53-48.53-48.53-85.53-85.53-85.53-85.530000000000
Tangible Book Value Per Share
-0.72-0.78-2.06-2.17-2.28-2.71-6.26-9.12-15.44-18.60----------
SEC Filings: 10-K · 10-Q